Latest news from the EMCDDA

European Drug Report 2020

22.09.2020 - How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2020 European Drug Report, the EMCDDA annual overview of the drug situation in Europe.

spacer3.jpg

Impact of COVID-19 on patterns of drug use and drug-related harms in Europe

06.2020 - The EMCDDA instigated a mixed-method trendspotter study to investigate the current situation.

EU Drug Markets — Impact of COVID-19

05.2020 - Joint publication from the EMCDDA and Europol.

 

 

 

 

 

 

 

Quick access to the EMCDDA main publications archives

 Databases


minilogoOFDT.jpg

The OFDT provides an online bibliographic database on addiction.

 
Books3.jpg

The EMCDDA provides a database on their publications of interest.

 

 

 

 

 

 

 

 

Drugs in Europe


2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.